A carregar...
Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour
BACKGROUND: Imatinib mesylate (IM) is the preferred treatment for the majority of patients with metastatic gastrointestinal stromal tumour (GIST). Low trough IM concentration (C(min)) values have been associated with poor clinical outcomes in GIST patients. However, there are few studies of repeated...
Na minha lista:
| Publicado no: | Clin Sarcoma Res |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5157085/ https://ncbi.nlm.nih.gov/pubmed/27999655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-016-0062-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|